Knight Therapeutics | GUD - Eigenkapital Und Reserven

Aktienkurs
8.64
Täglich Wechseln
0.15 1.77%
Monatlich
11.63%
Jährlich
47.95%
Q2 Prognose
8.51




Eigenkapital Und Reserven Veränderung Datum
Acasti Pharma USD 62.82M 732K 2025-09
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 2.15M 650K 2025-12
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 758.17M 22.16M 2025-12
Cronos Group USD 1.07B 20.24M 2026-03
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 7.41B 1.24B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Organigram Holdings CAD 369.46M 20.33M 2025-12
Organon & Co USD 903M 151M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.66B 53.6M 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03